Get started
Author

Olga Valeryevna Kalashnikova

Observed names: O Kalashnikova, O. Kalashnikova, O. V. Kalashnikova, O.V. Kalashnikova, Olga Kalashnikova, Olga V Kalashnikova, Olga V. Kalashnikova, Калашникова Ольга Валерьевна, О. V. Kalashnikova, О. В. Калашникова
ORCID: 0000-0002-8683-4270
Observed ORCID: 0000-0002-8683-4270
OpenAlex ID: A5038721630
Identification of the best cutoff points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis
2014 · Mikhail M. Kostik, Margarita F. Dubko, et al. · Seminars in Arthritis and Rheumatism · 48
Distinguishing Between Multisystem Inflammatory Syndrome, Associated With COVID-19 in Children and the Kawasaki Disease: Development of Preliminary Criteria Based on the Data of the Retrospective Multicenter Cohort Study
2021 · Mikhail M. Kostik, Liudmila V. Bregel, et al. · Frontiers in Pediatrics · 47
PDF
The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience
2022 · Mikhail M. Kostik, Rinat K. Raupov, et al. · Frontiers in Pediatrics · 39
PDF
Methotrexate treatment may prevent uveitis onset in patients with juvenile idiopathic arthritis: experiences and subgroup analysis in a cohort with frequent methotrexate use.
2016 · Mikhail M Kostik, Ekaterina V Gaidar, et al. · PubMed · 29
Heart Involvement in Multisystem Inflammatory Syndrome, Associated With COVID-19 in Children: The Retrospective Multicenter Cohort Data
2022 · Mikhail M. Kostik, Liudmila V. Bregel, et al. · Frontiers in Pediatrics · 25
PDF
Standard and increased canakinumab dosing to quiet macrophage activation syndrome in children with systemic juvenile idiopathic arthritis
2022 · Mikhail M. Kostik, Eugenia A. Isupova, et al. · Frontiers in Pediatrics · 23
PDF
Successful treatment with tocilizumab every 4 weeks of a low disease activity group who achieve a drug-free remission in patients with systemic-onset juvenile idiopathic arthritis
2015 · Mikhail M Kostik, Margarita F Dubko, et al. · Pediatric Rheumatology · 19
PDF
Determination of Risk Factors for Severe Life-Threatening Course of Multisystem Inflammatory Syndrome Associated with COVID-19 in Children
2023 · Ilia S. Avrusin, Natalia N. Abramova, et al. · Children · 16
PDF
Rituximab Biosimilar BCD020 Shows Superior Efficacy above Conventional Non-Biologics Treatment in Pediatric Lupus Nephritis: The Data of Retrospective Cohort Study
2023 · Mikhail Kostik, Elvira Kalashnikova, et al. · Biomedicines · 8
PDF
Proceedings of the 23rd Paediatric Rheumatology European Society Congress: part three
2017 · PRINTO/PRCSG, Riccardo Papa, et al. · Pediatric Rheumatology · 8
PDF
Current approaches to diagnosing and treating macrophage activation syndrome in children with rheumatic diseases
2015 · M. M. Kostik, M. F. Dubko, et al. · Modern Rheumatology Journal · 8
PDF
Using HScore for Evaluation of Hemophagocytosis in Multisystem Inflammatory Syndrome Associated with COVID-19 in Children
2024 · Ilia S. Avrusin, Natalia N. Abramova, et al. · Biomedicines · 7
PDF
COVID-19 Associated Vasculitis Confirmed by the Tissues RT-PCR: A Case Series Report
2023 · Konstantin E. Belozerov, Ilia S. Avrusin, et al. · Biomedicines · 7
PDF
Reasons for inactive disease and flare in systemic onset juvenile idiopathic arthritis patients during tocilizumab treatment.
2018 · Mikhail M Kostik, Eugenia A Isupova, et al. · PubMed · 7
Modern Approaches to Therapy for Children With Mucopolysaccharidosis
2014 · N. V. Buchinskaya, I. А. Chikova, et al. · Вопросы современной педиатрии · 6
Uveitis Is a Risk Factor for Juvenile Idiopathic Arthritis' Significant Flare in Patients Treated With Biologics
2022 · Mikhail M. Kostik, Ekaterina V. Gaidar, et al. · Frontiers in Pediatrics · 5
PDF
Experience in Rituximab Administration in Children with Systemic Lupus Erythematosus: a Retrospective Study of the Case Series
2016 · M. M. Kostik, E. M. Kuchinskaya, et al. · Вопросы современной педиатрии · 5
PDF
Skeletal manifestations for mucopolysaccharidoses of different types
2014 · Natalia V. Buchinskaia, М. Костик, et al. · CyberLeninK (CyberLeninka) · 5
Evaluation of the efficiency and safety of tocilizumab therapy in patients with systemic-onset juvenile idiopathic arthritis: results of a retrospective follow-up
2017 · M. M. Kostik, E. A. Isupova, et al. · Modern Rheumatology Journal · 4
PDF
Use of capillaroscopy in diagnosis of systemic diseases in children
2025 · A. A. Nurseitova, K. A. Kravtsova, et al. · Yakut Medical Journal · 3
The experience of rituximab therapy in patients with juvenile systemic lupus erythematosus: the preliminary results of two-center cohort study
2023 · E. M. Kalashnikova, R. K. Raupov, et al. · Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) · 3
HEART INJURY IN PATIENTS WITH MULTISYSTEM INFLAMMATORY SYNDROME ASSOCIATED WITH SARS-CоV-2: A DESCRIPTION OF A SERIES OF CLINICAL CASES
2021 · K.E. Belozerov, A.D. Kupreeva, et al. · PEDIATRIA Journal named after G N SPERANSKY · 3
The Use of Tocilizumab in 40 Patients With Polyarticular Juvenile Idiopathic Arthritis: the Results of a Retrospective Study
2017 · M. M. Kostik, I. A. Chikova, et al. · Вопросы современной педиатрии · 3
PDF
A130: Is the CCR5‐delta32 Mutation Protective Against Systemic‐Onset Juvenile Idiopathic Arthritis?
2014 · Vyacheslav Chasnyk, Elena Fedorova, et al. · Arthritis & Rheumatology · 3
Presence of uveitis as indicator of juvenile idiopathic arthritis severity: results of a retrospective cohort study
2023 · Alexandr A. Yakovlev, Ekaterina V. Gaidar, et al. · Pediatrician (St Petersburg) · 2
PDF
Works count: 82
Citation count: 373
H-index: 8
I10-index: 8
Year
Topic
Type